National Health

Q2 FY2026 EarningsFY26 Q2 results presented a mixed profile against consensus: revenue beat expectations at $121.3M vs. $112.5M (+7.83%), while GAAP diluted EPS of $1.15 significantly missed the $2.70 mean estimate (-57.41%). The top-line beat was primarily driven by aggressive expansion in the SHOP segment, where resident fees surged to $44.8M following the acquisition of 20 properties. However, the bottom-line miss was largely a timing issue, as the massive gain from the $560M NHC portfolio sale was recorded on July 1 (Q3), whereas consensus appears to have modeled the impact in Q2.